S1PR2

sphingosine-1-phosphate receptor 2, the group of Sphingosine 1-phosphate receptors

Basic information

Region (hg38): 19:10221433-10231331

Previous symbols: [ "EDG5", "DFNB68" ]

Links

ENSG00000267534NCBI:9294OMIM:605111HGNC:3169Uniprot:O95136AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive nonsyndromic hearing loss 68 (Strong), mode of inheritance: AR
  • autosomal recessive nonsyndromic hearing loss 68 (Strong), mode of inheritance: AR
  • hearing loss, autosomal recessive (Supportive), mode of inheritance: AR
  • nonsyndromic genetic hearing loss (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Deafness, autosomal recessive 68ARAudiologic/OtolaryngologicEarly recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic16703383; 26805784

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the S1PR2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the S1PR2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
32
clinvar
6
clinvar
39
missense
44
clinvar
5
clinvar
1
clinvar
50
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
3
clinvar
3
clinvar
6
Total 0 0 45 40 10

Variants in S1PR2

This is a list of pathogenic ClinVar variants found in the S1PR2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-10223706-G-A Likely benign (Jan 02, 2019)1199924
19-10223764-C-T Likely benign (Sep 24, 2018)1199706
19-10223767-A-C Benign (Jun 22, 2018)1270177
19-10223856-G-A not specified • S1PR2-related disorder Benign (Jan 29, 2024)506084
19-10223872-G-A Uncertain significance (May 13, 2022)2149547
19-10223872-G-T Inborn genetic diseases Uncertain significance (Feb 28, 2024)3157417
19-10223874-G-A not specified Likely benign (Aug 23, 2017)929888
19-10223880-C-T Likely benign (May 28, 2022)1588480
19-10223888-T-A Inborn genetic diseases Uncertain significance (Nov 17, 2023)3157416
19-10223907-G-A Likely benign (Feb 01, 2023)2833717
19-10223913-G-A Likely benign (Oct 04, 2022)2118319
19-10223920-C-A Inborn genetic diseases Uncertain significance (Sep 29, 2023)3157423
19-10223920-C-T Uncertain significance (Dec 06, 2023)1879416
19-10223921-G-A Autosomal recessive nonsyndromic hearing loss 68 Uncertain significance (May 01, 2024)1301661
19-10223925-T-C Likely benign (Feb 01, 2024)1618993
19-10223943-C-T Likely benign (Jan 29, 2024)2973543
19-10223951-C-T not specified • Inborn genetic diseases Conflicting classifications of pathogenicity (May 28, 2024)929890
19-10223957-G-A Inborn genetic diseases Uncertain significance (Dec 17, 2023)3157421
19-10223962-C-T Uncertain significance (Jun 14, 2023)1301201
19-10223963-G-A Inborn genetic diseases Conflicting classifications of pathogenicity (Oct 12, 2022)1212513
19-10223972-C-G Uncertain significance (May 21, 2022)1301247
19-10223983-G-A not specified Likely benign (Dec 02, 2023)929889
19-10223987-T-A S1PR2-related disorder Likely benign (Nov 07, 2023)1210475
19-10223987-T-G not specified • Autosomal recessive nonsyndromic hearing loss 68 Benign (Jan 31, 2024)506085
19-10223990-A-G Inborn genetic diseases Uncertain significance (Jan 22, 2024)3157420

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
S1PR2protein_codingprotein_codingENST00000590320 17429
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01830.9041257360101257460.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.531732400.7220.00001732217
Missense in Polyphen4881.1920.59119852
Synonymous0.9201071200.8930.00000958815
Loss of Function1.4948.760.4574.65e-789

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.00005290.0000527
Middle Eastern0.000.00
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for the lysosphingolipid sphingosine 1- phosphate (S1P). S1P is a bioactive lysophospholipid that elicits diverse physiological effect on most types of cells and tissues. When expressed in rat HTC4 hepatoma cells, is capable of mediating S1P-induced cell proliferation and suppression of apoptosis.;
Disease
DISEASE: Deafness, autosomal recessive, 68 (DFNB68) [MIM:610419]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:26805784}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Sphingolipid signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Small Ligand GPCRs;Signal Transduction of S1P Receptor;Signaling by GPCR;Signal Transduction;Lysosphingolipid and LPA receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling;Sphingosine 1-phosphate (S1P) pathway;S1P2 pathway (Consensus)

Recessive Scores

pRec
0.167

Intolerance Scores

loftool
0.137
rvis_EVS
-0.4
rvis_percentile_EVS
26.73

Haploinsufficiency Scores

pHI
0.136
hipred
N
hipred_score
0.468
ghis
0.488

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.155

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
S1pr2
Phenotype
integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; neoplasm; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype;

Zebrafish Information Network

Gene name
s1pr2
Affected structure
neuromast hair cell
Phenotype tag
abnormal
Phenotype quality
apoptotic

Gene ontology

Biological process
activation of MAPK activity;sphingosine-1-phosphate receptor signaling pathway;G protein-coupled receptor signaling pathway;positive regulation of cell population proliferation;positive regulation of peptidyl-threonine phosphorylation;actin cytoskeleton reorganization;filopodium assembly;negative regulation of excitatory postsynaptic potential;positive regulation of establishment of endothelial barrier
Cellular component
plasma membrane;integral component of membrane
Molecular function
G protein-coupled receptor binding;G protein-coupled receptor activity;integrin binding;protein binding;lipid binding;sphingosine-1-phosphate receptor activity